Metabolomics and diabetes: Analytical and computational approaches

Diabetes

Volumn 64, Issue 3, 2015, Pages 718-732

  Sas, Kelli M ^a   Karnovsky, Alla ^a   Michailidis, George ^b   Pennathur, Subramaniam ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BIOINFORMATICS; DIABETES MELLITUS; GENETIC VARIABILITY; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MATHEMATICAL ANALYSIS; METABOLIC FLUX ANALYSIS; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; STEADY STATE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; HUMAN; METABOLISM; PROCEDURES;

ANIMALS; DIABETES MELLITUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METABOLOMICS;

EID: 84962092236     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0509     Document Type: Article

References (138)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
2. Dunn WB, Wilson ID, Nicholls AW, Broadhurst D. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis 2012;4:2249-2264
3. Fan TW, Lane AN, Higashi RM, et al. Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM). Mol Cancer 2009;8:41
4. Lane AN, Fan TW, Bousamra M 2nd, Higashi RM, Yan J, Miller DM. Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer. OMICS 2011;15:173-182
5. Want EJ, Masson P, Michopoulos F, et al. Global metabolic profiling of animal and human tissues via UPLC-MS. Nat Protoc 2013;8:17-32
6. Keun HC, Athersuch TJ. Nuclear magnetic resonance (NMR)-based metabolomics. Methods Mol Biol 2011;708:321-334
7. Chen T, Cao Y, Zhang Y, et al. Random forest in clinical metabolomics for phenotypic discrimination and biomarker selection. Evid Based Complement Alternat Med 2013;2013:298183
8. Niewczas MA, Sirich TL, Mathew AV, et al. Uremic solutes and risk of endstage renal disease in type 2 diabetes: metabolomic study. Kidney Int 2014;85: 1214-1224
9. Salmons S, Jarvis JC, Mayne CN, et al. Changes in ATP, phosphocreatine, and 16 metabolites in muscle stimulated for up to 96 hours. Am J Physiol 1996; 271:C1167-C1171
10. Antoniewicz MR. 13C metabolic flux analysis: optimal design of isotopic labeling experiments. Curr Opin Biotechnol 2013;24:1116-1121
11. Choi J, Antoniewicz MR. Tandem mass spectrometry: a novel approach for metabolic flux analysis. Metab Eng 2011;13:225-233
12. Crown SB, Ahn WS, Antoniewicz MR. Rational design of 13C-labeling experiments for metabolic flux analysis in mammalian cells. BMC Syst Biol 2012;6:43
13. Huang X, Chen YJ, Cho K, Nikolskiy I, Crawford PA, Patti GJ. X13CMS: global tracking of isotopic labels in untargeted metabolomics. Anal Chem 2014;86:1632-1639
14. Lorenz MA, El Azzouny MA, Kennedy RT, Burant CF. Metabolome response to glucose in the b-cell line INS-1 832/13. J Biol Chem 2013;288: 10923-10935
15. Dunn WB, Broadhurst D, Begley P, et al.; Human Serum Metabolome (HUSERMET) Consortium. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011;6:1060-1083
16. Lorenz MA, Burant CF, Kennedy RT. Reducing time and increasing sensitivity in sample preparation for adherent mammalian cell metabolomics. Anal Chem 2011;83:3406-3414
17. Smolinska A, Blanchet L, Buydens LM, Wijmenga SS. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta 2012;750:82-97
18. Horai H, Arita M, Kanaya S, et al. MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom 2010;45:703-714
19. Smith CA, O'Maille G, Want EJ, et al. METLIN: a metabolite mass spectral database. Ther Drug Monit 2005;27:747-751
20. Sud M, Fahy E, Cotter D, et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res 2007;35:D527-D532
21. Wishart DS, Knox C, Guo AC, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009;37:D603-D610
22. Putluri N, Shojaie A, Vasu VT, et al. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. Cancer Res 2011;71:7376-7386
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300
24. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148: 839-843
25. Klipper-Aurbach Y, Wasserman M, Braunspiegel-Weintrob N, et al. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 1995;45:486-490
26. Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. 2nd ed. Springer series in statistics. New York, Springer-Verlag, 2009
27. Collett D. Modelling Survival Data in Medical Research. 2nd ed. Chapman & Hall/CRC texts in statistical science series. Boca Raton, Florida, Chapman & Hall/ CRC, 2003
28. Guo J, James G, Levina E, Michailidis G, Zhu J. Principal component analysis with sparse fused loadings. J Comput Graph Stat 2010;19:930-946
29. Kanehisa, M., Goto, S., Hattori, M., et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006;34:D354-D357
30. Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, Karp PD. Computational prediction of human metabolic pathways from the complete human genome. Genome Biol 2005;6:R2
31. Caspi R, Altman T, Dreher K, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res 2012;40:D742-D753
32. Ma H, Sorokin A, Mazein A, et al. The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol 2007;3:135
33. Duarte NC, Becker SA, Jamshidi N, et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A 2007;104:1777-1782
34. Sigurdsson MI, Jamshidi N, Steingrimsson E, Thiele I, Palsson BØ. A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. BMC Syst Biol 2010;4:140
35. Thiele I, Swainston N, Fleming RM, et al. A community-driven global reconstruction of human metabolism. Nat Biotechnol 2013;31:419-425
36. Hao T, Ma HW, Zhao XM, Goryanin I. Compartmentalization of the Edinburgh Human Metabolic Network. BMC Bioinformatics 2010;11:393
37. Paley SM, Karp PD. The Pathway Tools cellular overview diagram and Omics Viewer. Nucleic Acids Res 2006;34:3771-3778
38. García-Alcalde F, García-López F, Dopazo J, Conesa A. Paintomics: a web based tool for the joint visualization of transcriptomics and metabolomics data. Bioinformatics 2011;27:137-139
39. Junker BH, Klukas C, Schreiber F. VANTED: a system for advanced data analysis and visualization in the context of biological networks. BMC Bioinformatics 2006;7:109
40. Klukas, C. and F. Schreiber. Integration of-omics data and networks for biomedical research with VANTED. J Integr Bioinform 2010;7:112
41. Xia J, Wishart DS. MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 2010;26:2342-2344
42. Xia, J., Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 2009;37: W652-W660
43. Karnovsky A, Weymouth T, Hull T, et al. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics 2012;28:373-380
44. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13:2498-2504
45. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011;17:448-453
46. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-273
47. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLOS Comput Biol 2012;8:e1002375
48. Chagoyen M, Pazos F. MBRole: enrichment analysis of metabolomic data. Bioinformatics 2011;27:730-731
49. Xia J, Wishart DS. Metabolomic data processing, analysis, and interpretation using MetaboAnalyst. Curr Protoc Bioinformatics 2011;Chapter 14: Unit 14.10
50. Xia, J. and D.S. Wishart, MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res 2010; 38:W71-W77
51. Kuo TC, Tian TF, Tseng YJ. 3Omics: a web-based systems biology tool for analysis, integration and visualization of human transcriptomic, proteomic and metabolomic data. BMC Syst Biol 2013;7:64
52. Shojaie A, Michailidis G. Analysis of gene sets based on the underlying regulatory network. J Comput Biol 2009;16:407-426
53. Shojaie A, Michailidis G. Network enrichment analysis in complex experiments. Stat Appl Genet Mol Biol 2010;9:Article 22
54. Mitrea C, Taghavi Z, Bokanizad B, et al. Methods and approaches in the topology-based analysis of biological pathways. Front Physiol 2013;4:278
55. Li S, Park Y, Duraisingham S, et al. Predicting network activity from high throughput metabolomics. PLOS Comput Biol 2013;9:e1003123
56. Barupal DK, Haldiya PK, Wohlgemuth G, et al. MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics 2012; 13:99
57. Sartor MA, Ade A, Wright Z, et al. Metab2MeSH: annotating compounds with medical subject headings. Bioinformatics 2012;28:1408-1410
58. Duren W, Weymouth T, Hull T, et al. MetDisease-connecting metabolites to diseases via literature. Bioinformatics 2014;30:2239-2241
59. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
60. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-1350
61. Felig P, Marliss E, Cahill GF Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 1969;281:811-816
62. Floegel A, Stefan N, Yu Z, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 2013;62:639-648
63. Menni C, Fauman E, Erte I, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 2013;62:4270-4276
64. Renner S, Römisch-Margl W, Prehn C, et al. Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced b-cell mass. Diabetes 2012;61: 2166-2175
65. Suhre K, Meisinger C, Döring A, et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 2010;5:e13953
66. Wang TJ, Ngo D, Psychogios N, et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest 2013;123:4309-4317
67. Sell DR, Strauch CM, Shen W, Monnier VM. Aging, diabetes, and renal failure catalyze the oxidation of lysyl residues to 2-aminoadipic acid in human skin collagen: evidence for metal-catalyzed oxidation mediated by alphadicarbonyls. Ann N Y Acad Sci 2008;1126:205-209
68. Wijekoon EP, Skinner C, Brosnan ME, Brosnan JT. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can J Physiol Pharmacol 2004;82:506-514
69. Yuan W, Zhang J, Li S, Edwards JL. Amine metabolomics of hyperglycemic endothelial cells using capillary LC-MS with isobaric tagging. J Proteome Res 2011;10:5242-5250
70. Zeitoun-Ghandour S, Leszczyszyn OI, Blindauer CA, Geier FM, Bundy JG, Stürzenbaum SR. C. Elegans metallothioneins: response to and defence against ROS toxicity. Mol Biosyst 2011;7:2397-2406
71. Wang-Sattler R, Yu Z, Herder C, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 2012;8:615
72. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH. Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS ONE 2010;5:e15234
73. Zhang H, Saha J, Byun J, et al. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol 2008;295: F1071-F1081
74. Barreto FC, Barreto DV, Liabeuf S, et al.; European Uremic Toxin Work Group (EUTox). Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol 2009;4: 1551-1558
75. D'Agostino RB Jr, Hamman RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM; Insulin Resistance Atherosclerosis Study Investigators. Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2004;27:2234-2240
76. Schulze MB, Weikert C, Pischon T, et al. Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study. Diabetes Care 2009;32:2116-2119
77. Rhee EP, Cheng S, Larson MG, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 2011;121:1402-1411
78. Schwab U, Seppänen-Laakso T, Yetukuri L, et al.; GENOBIN Study Group. Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism - the GENOBIN study. PLoS ONE 2008;3:e2630
79. Mäkinen VP, Tynkkynen T, Soininen P, et al. Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). J Proteome Res 2012;11:1782-1790
80. Ho JE, Larson MG, Vasan RS, et al. Metabolite profiles during oral glucose challenge. Diabetes 2013;62:2689-2698
81. O'Connell TM. The complex role of branched chain amino acids in diabetes and cancer. Metabolites 2013;3:931-945
82. Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci STKE 2005;2005:pe4
83. Guan M, Xie L, Diao C, et al. Systemic perturbations of key metabolites in diabetic rats during the evolution of diabetes studied by urine metabonomics. PLoS ONE 2013;8:e60409
84. Li M, Wang X, Aa J, et al. GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy. Am J Physiol Renal Physiol 2013;304:F1317-F1324
85. Dutta T, Chai HS, Ward LE, et al. Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes. Diabetes 2012;61:1004-1016
86. Sharma K, Karl B, Mathew AV, et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol 2013;24: 1901-1912
87. Ahn SY, Nigam SK. Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis. Mol Pharmacol 2009;76:481-490
88. Wu W, Dnyanmote AV, Nigam SK. Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis. Mol Pharmacol 2011;79:795-805
89. Dugan LL, You YH, Ali SS, et al. AMPK dysregulation promotes diabetesrelated reduction of superoxide and mitochondrial function. J Clin Invest 2013; 123:4888-4899
90. Hummasti S, Hotamisligil GS. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ Res 2010;107:579-591
91. Kanter JE, Kramer F, Barnhart S, et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci U S A 2012;109:E715-E724
92. Nishizawa T, Kanter JE, Kramer F, et al. Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis. Cell Reports 2014;7:356-365
93. Rabinowitz JD, Purdy JG, Vastag L, Shenk T, Koyuncu E. Metabolomics in drug target discovery. Cold Spring Harb Symp Quant Biol 2011;76:235-246
94. Figarola JL, Singhal P, Rahbar S, Gugiu BG, Awasthi S, Singhal SS. COHSR4 reduces body weight, improves glycemic control and prevents hepatic steatosis in high fat diet-induced obese mice. PLoS ONE 2013;8:e83801
95. Koeth RA, Wang Z, Levison BS, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013;19: 576-585
96. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013;368:1575-1584
97. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011;472:57-63
98. Emilsson V, Thorleifsson G, Zhang B, et al. Genetics of gene expression and its effect on disease. Nature 2008;452:423-428
99. Ioannidis JP, Thomas G, Daly MJ. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 2009;10:318-329
100. Sieberts SK, Schadt EE. Moving toward a system genetics view of disease. Mamm Genome 2007;18:389-401
101. Ferrara CT, Wang P, Neto EC, et al. Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet 2008;4:e1000034
102. Gieger C, Geistlinger L, Altmaier E, et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet 2008;4:e1000282
103. Keurentjes JJ, Fu J, de Vos CH, et al. The genetics of plant metabolism. Nat Genet 2006;38:842-849
104. Shah SH, Hauser ER, Bain JR, et al. High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol 2009;5:258
105. Adamski J. Genome-wide association studies with metabolomics. Genome Med 2012;4:34
106. Adamski J, Suhre K. Metabolomics platforms for genome wide association studies - linking the genome to the metabolome. Curr Opin Biotechnol 2013;24: 39-47
107. Suhre K, Wallaschofski H, Raffler J, et al. A genome-wide association study of metabolic traits in human urine. Nat Genet 2011;43:565-569
108. Daly AK. Drug-induced liver injury: past, present and future. Pharmacogenomics 2010;11:607-611
109. Köttgen A, Pattaro C, Böger CA, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet 2010;42:376-384
110. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-713
111. Kettunen J, Tukiainen T, Sarin AP, et al. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 2012;44:269-276
112. An J, Muoio DM, Shiota M, et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 2004;10:268-274
113. Han CY, Umemoto T, Omer M, et al. NADPH oxidase-derived reactive oxygen species increases expression of monocyte chemotactic factor genes in cultured adipocytes. J Biol Chem 2012;287:10379-10393
114. Golej DL, Askari B, Kramer F, et al. Long-chain acyl-CoA synthetase 4 modulates prostaglandin E2 release from human arterial smooth muscle cells. J Lipid Res 2011;52:782-793
115. Magnes C, Sinner FM, Regittnig W, Pieber TR. LC/MS/MS method for quantitative determination of long-chain fatty acyl-CoAs. Anal Chem 2005;77: 2889-2894
116. Krank J, Murphy RC, Barkley RM, Duchoslav E, McAnoy A. Qualitative analysis and quantitative assessment of changes in neutral glycerol lipid molecular species within cells. Methods Enzymol 2007;432:1-20
117. Leiker TJ, Barkley RM, Murphy RC. Analysis of diacylglycerol molecular species in cellular lipid extracts by normal-phase LC-electrospray mass spectrometry. Int J Mass Spectrom 2011;305:103-109
118. Kugler F, Graneis S, Schreiter PP, Stintzing FC, Carle R. Determination of free amino compounds in betalainic fruits and vegetables by gas chromatography with flame ionization and mass spectrometric detection. J Agric Food Chem 2006;54:4311-4318
119. Xie G, Zhong W, Li H, et al. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption. FASEB J 2013;27:3583-3593
120. Murphy RC, Leiker TJ, Barkley RM. Glycerolipid and cholesterol ester analyses in biological samples by mass spectrometry. Biochim Biophys Acta 2011;1811:776-783
121. Lee SH, Williams MV, DuBois RN, Blair IA. Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry. Rapid Commun Mass Spectrom 2003;17:2168-2176
122. Schneider C, Yu Z, Boeglin WE, Zheng Y, Brash AR. Enantiomeric separation of hydroxy and hydroperoxy eicosanoids by chiral column chromatography. Methods Enzymol 2007;433:145-157
123. Quehenberger O, Armando AM, Dennis EA. High sensitivity quantitative lipidomics analysis of fatty acids in biological samples by gas chromatographymass spectrometry. Biochim Biophys Acta 2011;1811:648-656
124. Ivanova PT, Milne SB, Byrne MO, Xiang Y, Brown HA. Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. Methods Enzymol 2007;432:21-57
125. Lemons JM, Feng XJ, Bennett BD, et al. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010;8:e1000514
126. Han X, Yang K, Gross RW. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev 2012;31:134-178
127. Quehenberger O, Armando AM, Brown AH, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res 2010;51:3299-3305
128. Coulier L, van Kampen JJ, de Groot R, et al. Simultaneous determination of endogenous deoxynucleotides and phosphorylated nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cells using ion-pair liquid chromatography coupled to mass spectrometry. Proteomics Clin Appl 2008;2: 1557-1562
129. Mamer O, Gravel SP, Choinière L, Chénard V, St-Pierre J, Avizonis D. The complete targeted profile of the organic acid intermediates of the citric acid cycle using a single stable isotope dilution analysis, sodium borodeuteride reduction and selected ion monitoring GC/MS. Metabolomics 2013;9:1019-1030
130. Evans C, Bogan KL, Song P, Burant CF, Kennedy RT, Brenner C. NAD+ metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity. BMC Chem Biol 2010;10:2
131. Vivekanandan-Giri A, Byun J, Pennathur S. Quantitative analysis of amino acid oxidation markers by tandem mass spectrometry. Methods Enzymol 2011;491:73-89
132. Cui T, Schopfer FJ, Zhang J, et al. Nitrated fatty acids: endogenous antiinflammatory signaling mediators. J Biol Chem 2006;281:35686-35698
133. Levison BS, Zhang R, Wang Z, Fu X, DiDonato JA, Hazen SL. Quantification of fatty acid oxidation products using online high-performance liquid chromatography tandem mass spectrometry. Free Radic Biol Med 2013;59:2-13
134. Sullards MC, Allegood JC, Kelly S, et al. Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics. Methods Enzymol 2007;432:83-115
135. Wooding KM, Auchus RJ. Mass spectrometry theory and application to adrenal diseases. Mol Cell Endocrinol 2013;371:201-207
136. McDonald JG, Smith DD, Stiles AR, Russell DW. A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma. J Lipid Res 2012;53:1399-1409
137. Kuhara T, Ohse M, Inoue Y, Cooper AJ. A GC/MS-based metabolomic approach for diagnosing citrin deficiency. Anal Bioanal Chem 2011;400:1881-1894
138. Martens-Lobenhoffer J, Bode-Böger SM. Mass spectrometric quantification of L-arginine and its pathway related substances in biofluids: the road to maturity. J Chromatogr B Analyt Technol Biomed Life Sci 2014;964:89-102